Viekira Pak Effective Without Ribavirin
Share
Follow Us
The Editors at Hepatitis Central
June 26, 2015
Learn about Viekira Pak and its success as a standalone treatment for Hepatitis C.
AbbVie hepatitis C cocktail succeeds in late-stage study
June 24, 2015
AbbVie Inc said on Wednesday that its hepatitis C cocktail Viekira Pak was effective whether or not it was used in combination with the compound ribavirin against the most common form of the disease, according to data from a late-stage study.
Viekira Pak, a combination of the drugs Viekirax and Exviera, was approved in December for use as both a standalone treatment and in tandem with ribavirin, a broad-spectrum antiviral approved in 1998.
Continue reading this entire article:
http://www.foxnews.com/health/2015/06/24/abbvie-hepatitis-c-cocktail-succeeds-in-late-stage-study/
